These results suggest that kaempferol can be used as a chemosensitizer to enhance the therapeutic effects of ERL and reduce its toxicit by inhibiting the PI3K/Akt and EGFR signaling pathways, and that it may be a clinical candidate for the effective treatment of pancreatic cancer [80]. Here, AKT1 is linked to familial pancreatic carcinoma.